Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

被引:0
|
作者
Ye Qing [1 ]
Yuan Xiaolei [1 ]
Zhou Jie [1 ]
Yuan Canxing [1 ]
Yang Xuming [2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Neurol, Shanghai 200032, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Dept Acupuncture Inst, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
MAP kinase signaling system; Inflammation; Apoptosis; Parkinsondisease; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MOUSE MODEL; CELL-DEATH; JNK; INHIBITION; ACTIVATION; EXPRESSION; SUBACUTE;
D O I
暂无
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
OBJECTIVE: To investigate the regulatory mechanism of the c-Jun N-terminal protein kinase (JNK) signaling pathway in substantia nigra (SN) dopaminergic neurons inflammation and apoptosis, and the neuroprotective effect of Zishenpingchan granules in mice with Parkinson's disease (PD) induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). METHODS: PD model mice were established by intraperitoneally injecting MPTP. Sixty mice were divided into a model group, Traditional Chinese Medicine (TCM) group and control group. The mice of the TCM group were administered Zishenpingchan granules 7 days before PD induction. Seven days after PD induction, we examined locomotor activity, and performed the rotarod test and swimming test, to evaluate limb movement function. Furthermore, we used immunohistochemistry and western blotting to examine the expression of tyrosine hydroxylase (TH), cyclooxygenase-2 (Cox-2), caspase-3 and p-JNK. The terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) method was used to examine neuron apoptosis in the SN. RESULTS: Compared with the control group, the mean score of locomotor activity, rotarod test and swimming test was significantly lower in the model group (P < 0.05); the TH-positive neuron expression was significantly decreased in the SN pars compacta (SNpc); the protein expression levels of Cox-2, caspase-3 and p-JNK was obviously increased; and the number of TUNEL-positive neurons in the SN was increased (P < 0.01). Compared with the model group, the mean score of neurobehavioral tests in the TCM group was obviously higher, the loss of TH-positive neurons ignificantly decreased, the protein expression levels of Cox-2, caspase-3 and p-JNK obviously decreased, and the number of TUNEL-positive neurons in the SN clearly decreased (P < 0.01). CONCLUSION: The JNK pathway plays an important role in the regulation of inflammation and apoptosis in nigral cells in PD mice. TCM can suppress the over-activation of the JNK pathway in the SN, and alleviate the inflammatory response in nigral cells and dopaminergic neuron apoptosis in PD mice. (C) 2017 JTCM. All rights reserved.
引用
收藏
页码:244 / 251
页数:8
相关论文
共 50 条
  • [21] Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson's disease
    Kadoguchi, Naoto
    Okabe, Shinji
    Yamamura, Yukio
    Shono, Misaki
    Fukano, Tatsuya
    Tanabe, Akie
    Yokoyama, Hironori
    Kasahara, Jiro
    BMC NEUROSCIENCE, 2014, 15
  • [22] EFFECT OF AMPHETAMINE ON 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) NEUROTOXICITY IN MICE
    SERSHEN, H
    MASON, MF
    REITH, MEA
    HASHIM, A
    LAJTHA, A
    NEUROPHARMACOLOGY, 1986, 25 (08) : 927 - 930
  • [23] Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson’s disease
    Naoto Kadoguchi
    Shinji Okabe
    Yukio Yamamura
    Misaki Shono
    Tatsuya Fukano
    Akie Tanabe
    Hironori Yokoyama
    Jiro Kasahara
    BMC Neuroscience, 15
  • [24] Neuroprotective Effect of Neferine, an Alkaloid against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson's Disease Mouse Model
    Jing, Shendong
    Wang, Zhenhai
    Zhang, Jun
    Li, Xianfeng
    Huang, Ruifei
    PHARMACOGNOSY MAGAZINE, 2021, 17 (73) : 186 - 192
  • [25] Therapeutic effect of zonisamide on the nigrostriatal dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson's disease
    Yokoyama, Hironori
    Matsueda, Misato
    Yano, Ryouhei
    Kasahara, Jiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 115P - 115P
  • [26] Mulberrin attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease by promoting Wnt/β-catenin signaling pathway
    Cao, Wenhui
    Dong, Yan
    Zhao, Weina
    Lu, Xin
    Sun, Li
    JOURNAL OF CHEMICAL NEUROANATOMY, 2019, 98 : 63 - 70
  • [27] Regulation of Dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
    Hayley, S
    Crocker, SJ
    Smith, PD
    Shree, T
    Jackson-Lewis, V
    Przedborski, S
    Mount, M
    Slack, R
    Anisman, H
    Park, DS
    JOURNAL OF NEUROSCIENCE, 2004, 24 (08): : 2045 - 2053
  • [28] 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated adult zebrafish as a model for Parkinson's Disease
    Bagwell, Emmeline
    Shin, Minhyun
    Henkel, Nicole
    Migliaccio, Doris
    Peng, Congyue
    Larsen, Jessica
    NEUROSCIENCE LETTERS, 2024, 842
  • [29] The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model - A tool to explore the pathogenesis of Parkinson's disease
    Przedborski, S
    Vila, M
    PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON, 2003, 991 : 189 - 198
  • [30] Levodopa-induced hyperactivity in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    Nicholas, Anthony P.
    MOVEMENT DISORDERS, 2007, 22 (01) : 99 - 104